![PCE artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts124/v4/94/32/1a/94321aaa-4adf-3df2-4810-f996719b6b1e/mza_11695467358112480520.jpg/100x100bb.jpg)
GLP-1 RAs: What Patients Need To Know
PCE
English - March 26, 2021 17:18 - 18 minutes - 16.7 MB - ★★★★ - 6 ratingsCourses Education Science Life Sciences app education np education podcasts for credit app medicine pa education np medicine pa medicine ce podcasts app podcasts cme podcasts Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Managing Pulmonary Arterial Hypertension
Next Episode: GLP-1 RAs: Which Ones for Which Patients?
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now firmly established as guideline-recommended antiglycemic agents of choice in patients with type 2 diabetes, especially when comorbid disease is evident or when the patient is at high risk for such conditions. In this second of two podcasts, Davida Kruger, NP and Anne Peters, MD share tips and pearls for treating patients with type 2 diabetes using GLP-1 RAs, including when to choose a GLP-1 RA, how to broach the topic of a first injectable, when an oral agent is preferred, strategies for encouraging lifestyle modifications, and practical advice on preparing and monitoring patients with respect to GLP1-RA therapy.
This episode is available for CE/CME credit.